# Dyslipidemia

Condition · id `cardio:dyslipidemia` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Dyslipidemias

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A group of conditions in which the levels of fats (lipids) in the blood are abnormal. This can mean high total cholesterol, high triglycerides, low HDL cholesterol or raised LDL cholesterol. Too much cholesterol can build up as plaque in the artery walls.

## Technical summary

MeSH descriptor D050171, a broad heading that MeSH marks as general. It is the parent of the high cholesterol and high triglycerides pages in this atlas. The evidence recorded here is descriptive: a MeSH scope note and two MedlinePlus patient pages.

## Claims, with the population each applies to

## Context: People with high cholesterol or high triglycerides (MedlinePlus patient pages and MeSH)

Recipient: Mixed recipients; Population: People with abnormal blood fat levels, such as high cholesterol or high triglycerides, as described by MedlinePlus patient pages and MeSH. MedlinePlus says younger people, including children and teens, can also have high cholesterol.; Care setting: Not stated; patient information pages and a vocabulary; Geography: Not stated; United States federal health agencies; Life stage: All ages; the cholesterol page says children and teens can also have high cholesterol; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (descriptive page)

### MeSH describes dyslipidemia as abnormal levels of fats (lipids) in the blood, including too much or too little. An abnormal profile may include high total cholesterol, high triglycerides, low HDL cholesterol and raised LDL cholesterol. MedlinePlus says that too much cholesterol in the blood can combine with other substances to form plaque, and that a high level of triglycerides can raise the risk of heart diseases such as coronary artery disease.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Mixed recipients; Population: People with abnormal blood fat levels, such as high cholesterol or high triglycerides, as described by MedlinePlus patient pages and MeSH. MedlinePlus says younger people, including children and teens, can also have high cholesterol.; Care setting: Not stated; patient information pages and a vocabulary; Geography: Not stated; United States federal health agencies; Life stage: All ages; the cholesterol page says children and teens can also have high cholesterol; Gestational age: Not reported; Postnatal age: Not reported; Follow-up: Not applicable (descriptive page)
- Limitations: MeSH is a vocabulary and its scope note sets no thresholds. A patient-information or vocabulary source: it describes the condition and the direction of any risk. It gives no size for the risk, no time frame and no comparison group, and it is not clinical advice.
- Last checked: 2026-10-30
- Sources:
  1. Supports: MeSH scope note for descriptor D050171 (Dyslipidemias) (Dataset, edition MeSH linked-data record of the preferred concept M0010831 of descriptor D050171, fetched 2026-10-30. The scope note is on this concept record, not on the descriptor record.) <https://id.nlm.nih.gov/mesh/M0010831>
     Locator: scopeNote.@value. Retrieved 2026-10-30T19:50:44Z. Source state: Current. Version fingerprint: 32824065c17b49aa6007d7d523ac33514fa5dafd0286380cb76c43c17dfce74d.
     How it applies: MeSH scope note for the descriptor.
  2. Supports: Cholesterol (MedlinePlus health topic) (Webpage, edition Page fetched 2026-10-30.) <https://medlineplus.gov/cholesterol.html>
     Locator: Summary, What is cholesterol?, para 2. Retrieved 2026-10-30T19:19:36Z. Source state: Current. Version fingerprint: 08257871095c35d788ec0fb8751b17ca1c4047c6dcf6e6bf2c88bff852084322.
     How it applies: MedlinePlus on cholesterol and plaque.
  3. Supports: Triglycerides (MedlinePlus health topic) (Webpage, edition Page fetched 2026-10-30.) <https://medlineplus.gov/triglycerides.html>
     Locator: Summary, What are triglycerides?, para 3. Retrieved 2026-10-30T19:19:38Z. Source state: Current. Version fingerprint: b7cd13120948ff2eeeebcfe6fd34831554fe9cfe21875cc5da03fbe7d3adb110.
     How it applies: MedlinePlus on triglycerides and heart disease.

## Connected pages

- Filed under this front: Prevention and lifestyle (`cardio:front-prevention-and-lifestyle`)
- LDL cholesterol, a blood measure: LDL cholesterol blood test (`cardio:ldl-cholesterol`)
- Related to: Lipoprotein(a) (`cardio:lipoprotein-a`)
- Has subtype: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Has subtype: High triglycerides (`cardio:hypertriglyceridemia`)
- Evaluated for this: Atorvastatin (`cardio:atorvastatin`) [a claim, not a settled fact; see claim `cardio:claim-fda-atorvastatin-label-indications` and its context]
- Evaluated for this: Fenofibrate (`cardio:fenofibrate`) [a claim, not a settled fact; see claim `cardio:claim-fda-fenofibrate-label-indications` and its context]
- Evaluated for this: Pitavastatin (`cardio:pitavastatin`) [a claim, not a settled fact; see claim `cardio:claim-fda-pitavastatin-label-indications` and its context]
- Evaluated for this: Pravastatin (`cardio:pravastatin`) [a claim, not a settled fact; see claim `cardio:claim-fda-pravastatin-label-indications` and its context]
- Evaluated for this: Simvastatin (`cardio:simvastatin`) [a claim, not a settled fact; see claim `cardio:claim-fda-simvastatin-label-indications` and its context]
- Related to: Lipid panel (cholesterol and triglyceride blood test) (`cardio:lipid-panel`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 465 registry trials

## Provenance

Content hash: 21fb3dfb777a4105fb16354ec83386a35e8fea2f5223fb3e26bce7f6630a8b33
Last substantive edit: 2026-10-30
Evidence last checked: 2026-10-30
